|
US4751087A
(en)
*
|
1985-04-19 |
1988-06-14 |
Riker Laboratories, Inc. |
Transdermal nitroglycerin delivery system
|
|
EP0268680A4
(de)
*
|
1986-05-29 |
1990-04-10 |
Vnii Ispytatel Med Tech |
Antitumorfilm aus biologisch abbaubaren polymeren.
|
|
AU607172B2
(en)
*
|
1986-12-22 |
1991-02-28 |
Cygnus, Inc. |
Diffusion matrix for transdermal drug administration
|
|
DE3643987A1
(de)
*
|
1986-12-22 |
1988-06-23 |
Lohmann Therapie Syst Lts |
Basische, wirkstoffdurchlaessige haftklebende polymermasse, insbesondere zum einsatz mit basischen wirkstoffen, verfahren zu ihrer herstellung und ihre verwendung
|
|
US4818541A
(en)
*
|
1987-08-19 |
1989-04-04 |
Schering Corporation |
Transdermal delivery of enantiomers of phenylpropanolamine
|
|
DE3823070A1
(de)
*
|
1988-07-07 |
1990-02-22 |
Kettelhack Riker Pharma Gmbh |
Selbstklebendes heftpflaster
|
|
CA2065311C
(en)
*
|
1989-09-08 |
2000-01-11 |
Chia-Ming Chiang |
Solid matrix system for transdermal drug delivery
|
|
US5252334A
(en)
*
|
1989-09-08 |
1993-10-12 |
Cygnus Therapeutic Systems |
Solid matrix system for transdermal drug delivery
|
|
JP3273430B2
(ja)
*
|
1989-12-28 |
2002-04-08 |
日東電工株式会社 |
エストロゲン含有ゲル製剤
|
|
US5204109A
(en)
*
|
1989-12-28 |
1993-04-20 |
Nitto Denko Corporation |
Percutaneous gel preparation
|
|
EP0436203B1
(en)
*
|
1989-12-28 |
1996-04-03 |
Nitto Denko Corporation |
Percutaneous gel preparation
|
|
JPH07116032B2
(ja)
*
|
1990-04-06 |
1995-12-13 |
積水化学工業株式会社 |
ニトログリセリン貼付剤
|
|
US5202125A
(en)
*
|
1990-12-10 |
1993-04-13 |
Theratech, Inc. |
Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes
|
|
JPH04261119A
(ja)
*
|
1991-02-13 |
1992-09-17 |
Lintec Corp |
経皮吸収型貼付剤
|
|
WO1992022292A1
(de)
|
1991-06-10 |
1992-12-23 |
Schwarz Pharma Ag |
Nitroglycerin-pflaster und verfahren zu seiner herstellung
|
|
DE4229230C2
(de)
*
|
1992-09-02 |
1997-01-16 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit Pentetrazol als Wirkstoff
|
|
US5489624A
(en)
*
|
1992-12-01 |
1996-02-06 |
Minnesota Mining And Manufacturing Company |
Hydrophilic pressure sensitive adhesives
|
|
US5762952A
(en)
*
|
1993-04-27 |
1998-06-09 |
Hercon Laboratories Corporation |
Transdermal delivery of active drugs
|
|
US5613958A
(en)
*
|
1993-05-12 |
1997-03-25 |
Pp Holdings Inc. |
Transdermal delivery systems for the modulated administration of drugs
|
|
EP0717761A4
(en)
*
|
1993-08-19 |
1998-01-07 |
Cygnus Therapeutic Systems |
WATER-SOLUBLE, PRESSURE-SENSITIVE AND MUCOADHESIVE ADHESIVE AND DEVICE FOR POSITIONING IT IN A MUCUTINE BODY CAVE
|
|
DE4403487C2
(de)
*
|
1994-02-04 |
2003-10-16 |
Lohmann Therapie Syst Lts |
Arznei-Pflaster mit UV-vernetzbaren Acrylat-Copolymeren
|
|
AU5299996A
(en)
*
|
1995-02-23 |
1996-09-11 |
Cygnus, Inc. |
Water-soluble pressure-sensitive mucoadhesive
|
|
US5601839A
(en)
*
|
1995-04-26 |
1997-02-11 |
Theratech, Inc. |
Triacetin as a penetration enhancer for transdermal delivery of a basic drug
|
|
US5985317A
(en)
*
|
1996-09-06 |
1999-11-16 |
Theratech, Inc. |
Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
|
|
DE19706824C1
(de)
|
1997-02-21 |
1998-03-26 |
Lohmann Therapie Syst Lts |
Transdermales oder topisches Plastersystem mit Polyacrylatmatrix mit verbesserten physikalischen Eigenschaften
|
|
GB9704022D0
(en)
*
|
1997-02-26 |
1997-04-16 |
York Rehabilitation Limited |
Protective barrier composition
|
|
US20020018754A1
(en)
*
|
1999-03-15 |
2002-02-14 |
Paul Albert Sagel |
Shapes for tooth whitening strips
|
|
US6096328A
(en)
*
|
1997-06-06 |
2000-08-01 |
The Procter & Gamble Company |
Delivery system for an oral care substance using a strip of material having low flexural stiffness
|
|
GB9714650D0
(en)
*
|
1997-07-11 |
1997-09-17 |
Strakan Ltd |
Block copolymer
|
|
US6183770B1
(en)
|
1999-04-15 |
2001-02-06 |
Acutek International |
Carrier patch for the delivery of agents to the skin
|
|
AU5907300A
(en)
|
1999-07-02 |
2001-01-22 |
Procter & Gamble Company, The |
Compositions comprising organosiloxane resins for delivering xylitol to the oralcavity
|
|
US6890553B1
(en)
|
1999-07-08 |
2005-05-10 |
Johnson & Johnson Consumer Companies, Inc. |
Exothermic topical delivery device
|
|
DE19940238A1
(de)
|
1999-08-25 |
2001-03-01 |
Lohmann Therapie Syst Lts |
Wirkstoffhaltiges therapeutisches System zur Applikation auf der Haut mit mindestens zwei polymerhaltigen Schichten
|
|
EP1318843B1
(en)
*
|
2000-09-19 |
2013-04-17 |
Henkel AG & Co. KGaA |
Acryl adhesive useful in transdermal drug delivery systems
|
|
US6709716B2
(en)
*
|
2001-04-27 |
2004-03-23 |
3M Innovative Properties Company |
Microemulsion compositions and methods of making and using same
|
|
US20070281003A1
(en)
*
|
2001-10-12 |
2007-12-06 |
Fuisz Richard C |
Polymer-Based Films and Drug Delivery Systems Made Therefrom
|
|
US20190328679A1
(en)
|
2001-10-12 |
2019-10-31 |
Aquestive Therapeutics, Inc. |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
|
US20060039958A1
(en)
*
|
2003-05-28 |
2006-02-23 |
Monosolrx, Llc. |
Multi-layer films having uniform content
|
|
US7425292B2
(en)
*
|
2001-10-12 |
2008-09-16 |
Monosol Rx, Llc |
Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
|
|
US7666337B2
(en)
*
|
2002-04-11 |
2010-02-23 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
|
US8765167B2
(en)
*
|
2001-10-12 |
2014-07-01 |
Monosol Rx, Llc |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
|
US8603514B2
(en)
|
2002-04-11 |
2013-12-10 |
Monosol Rx, Llc |
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|
|
US8900497B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for making a film having a substantially uniform distribution of components
|
|
US20110033542A1
(en)
|
2009-08-07 |
2011-02-10 |
Monosol Rx, Llc |
Sublingual and buccal film compositions
|
|
US7357891B2
(en)
|
2001-10-12 |
2008-04-15 |
Monosol Rx, Llc |
Process for making an ingestible film
|
|
US20100021526A1
(en)
*
|
2001-10-12 |
2010-01-28 |
Monosol Rx, Llc |
Ph modulated films for delivery of actives
|
|
US7910641B2
(en)
*
|
2001-10-12 |
2011-03-22 |
Monosol Rx, Llc |
PH modulated films for delivery of actives
|
|
US11207805B2
(en)
|
2001-10-12 |
2021-12-28 |
Aquestive Therapeutics, Inc. |
Process for manufacturing a resulting pharmaceutical film
|
|
US8900498B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for manufacturing a resulting multi-layer pharmaceutical film
|
|
US20070154527A1
(en)
*
|
2001-10-12 |
2007-07-05 |
Monosoirx, Llc |
Topical film compositions for delivery of actives
|
|
US8663687B2
(en)
|
2001-10-12 |
2014-03-04 |
Monosol Rx, Llc |
Film compositions for delivery of actives
|
|
US10285910B2
(en)
|
2001-10-12 |
2019-05-14 |
Aquestive Therapeutics, Inc. |
Sublingual and buccal film compositions
|
|
US8017150B2
(en)
*
|
2002-04-11 |
2011-09-13 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
|
JP4295467B2
(ja)
|
2002-04-12 |
2009-07-15 |
日東電工株式会社 |
貼付剤およびその製造方法
|
|
US6949240B2
(en)
*
|
2002-05-23 |
2005-09-27 |
The Procter & Gamble Company |
Tooth whitening products
|
|
JP4323138B2
(ja)
*
|
2002-06-05 |
2009-09-02 |
日東電工株式会社 |
経皮吸収型製剤およびその製造方法
|
|
CA2505796C
(en)
*
|
2002-07-22 |
2012-01-03 |
Monosolrx Llc |
Packaging and dispensing of rapid dissolve dosage form
|
|
US8524200B2
(en)
|
2002-09-11 |
2013-09-03 |
The Procter & Gamble Company |
Tooth whitening products
|
|
US20050019277A1
(en)
*
|
2002-09-11 |
2005-01-27 |
The Procter & Gamble Company |
Tooth whitening products
|
|
US20070059351A1
(en)
*
|
2003-10-17 |
2007-03-15 |
Murrell George A C |
Transdermal patches containing a nitric oxide-donor and a second active agent and associated methods
|
|
US20060286159A1
(en)
*
|
2003-10-17 |
2006-12-21 |
Calvert Murrell George A |
Treatment of persistent active tendinopathy using transdermal glyceryl trinitrate providing durability of effect
|
|
US20070053966A1
(en)
*
|
2003-10-17 |
2007-03-08 |
Robert Ang |
Medicated orthopedic support structures for treatment of damaged musculoskeletal tissue
|
|
US20060286158A1
(en)
*
|
2003-10-17 |
2006-12-21 |
Calvert Murrell George A |
Treatment of overuse tendinopathy using transdermal nitric oxide-generating agents
|
|
US7619007B2
(en)
|
2004-11-23 |
2009-11-17 |
Adamas Pharmaceuticals, Inc. |
Method and composition for administering an NMDA receptor antagonist to a subject
|
|
BRPI0518483A2
(pt)
|
2004-11-23 |
2008-11-18 |
Neuromolecular Pharmaceuticals Inc |
composiÇço compreendendo uma matriz ou revestimento de liberaÇço controlada e um antagonista de receptor de nmda, mÉtodo para administraÇço de tal antagonista de nmda a um paciente
|
|
BRPI0607017B8
(pt)
|
2005-04-06 |
2021-05-25 |
Adamas Pharmaceuticals Inc |
composição farmacêutica compreendendo memantina e donezepil, e seu uso para o tratamento de condições relacionadas ao snc
|
|
US20070212703A1
(en)
*
|
2005-09-27 |
2007-09-13 |
Stemmer Willem P |
Proteinaceous pharmaceuticals and uses thereof
|
|
US7846445B2
(en)
*
|
2005-09-27 |
2010-12-07 |
Amunix Operating, Inc. |
Methods for production of unstructured recombinant polymers and uses thereof
|
|
US20090099031A1
(en)
*
|
2005-09-27 |
2009-04-16 |
Stemmer Willem P |
Genetic package and uses thereof
|
|
US7855279B2
(en)
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
|
CA2636026A1
(en)
*
|
2006-01-20 |
2007-07-26 |
Monosol Rx, Llc |
Film lined pouch and method of manufacturing this pouch
|
|
US20070202155A1
(en)
*
|
2006-02-03 |
2007-08-30 |
Cure Therapeutics, Inc. |
Low dose no donor-containing transdermal patch
|
|
US20070259026A1
(en)
*
|
2006-04-20 |
2007-11-08 |
Robert Ang |
Vasodialating dressing for use with intravenous catheters
|
|
CN101516331A
(zh)
*
|
2006-09-20 |
2009-08-26 |
莫诺索尔克斯有限公司 |
含有抗泡沫调味剂的可食用水溶性膜
|
|
US20080081071A1
(en)
*
|
2006-09-29 |
2008-04-03 |
Pradeep Sanghvi |
Film Embedded Packaging and Method of Making Same
|
|
BRPI0815416A2
(pt)
*
|
2007-08-15 |
2014-10-21 |
Amunix Inc |
Composições e métodos para modificar propriedades de polipeptídeos biologicamente ativos
|
|
WO2010091122A1
(en)
*
|
2009-02-03 |
2010-08-12 |
Amunix, Inc. |
Extended recombinant polypeptides and compositions comprising same
|
|
AU2010258892B2
(en)
|
2009-06-08 |
2015-08-13 |
Amunix Operating Inc. |
Growth hormone polypeptides and methods of making and using same
|
|
AU2010258898B8
(en)
|
2009-06-08 |
2015-02-05 |
Amunix Operating Inc. |
Glucose-regulating polypeptides and methods of making and using same
|
|
US8475832B2
(en)
|
2009-08-07 |
2013-07-02 |
Rb Pharmaceuticals Limited |
Sublingual and buccal film compositions
|
|
BR112012004094A2
(pt)
|
2009-08-24 |
2016-03-08 |
Amunix Operating Inc |
composições de fator vii de coagulação e métodos para fazer e usar as mesmas
|
|
CN106389381A
(zh)
|
2009-12-02 |
2017-02-15 |
阿达玛斯医药公司 |
金刚烷胺组合物及其使用方法
|
|
EP4450523A3
(en)
|
2010-04-02 |
2025-03-12 |
Amunix Pharmaceuticals, Inc. |
Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods of making and using same
|
|
ES2569339T3
(es)
|
2010-06-10 |
2016-05-10 |
Midatech Ltd. |
Sistemas de administración de película de nanopartículas
|
|
DE102010024105A1
(de)
*
|
2010-06-17 |
2011-12-22 |
Grünenthal GmbH |
Transdermale Verabreichung von Memantin
|
|
US9149959B2
(en)
|
2010-10-22 |
2015-10-06 |
Monosol Rx, Llc |
Manufacturing of small film strips
|
|
LT2822577T
(lt)
|
2012-02-15 |
2019-03-25 |
Bioverativ Therapeutics Inc. |
Rekombinantiniai faktoriaus viii baltymai
|
|
HRP20221531T1
(hr)
|
2012-02-15 |
2023-02-17 |
Bioverativ Therapeutics Inc. |
Pripravci faktora viii i postupci dobivanja i korištenja istih
|
|
CA2888199C
(en)
|
2012-10-17 |
2019-06-25 |
The Procter & Gamble Company |
Strip for the delivery of an oral care active and methods for applying oral care actives
|
|
US10154971B2
(en)
|
2013-06-17 |
2018-12-18 |
Adamas Pharma, Llc |
Methods of administering amantadine
|
|
EP3033097B1
(en)
|
2013-08-14 |
2021-03-10 |
Bioverativ Therapeutics Inc. |
Factor viii-xten fusions and uses thereof
|
|
MX2018001497A
(es)
|
2015-08-03 |
2018-05-15 |
Bioverativ Therapeutics Inc |
Proteinas de fusion de factor ix y metodos para producirlas y usarlas.
|
|
US12433850B2
(en)
|
2016-05-05 |
2025-10-07 |
Aquestive Therapeutics, Inc. |
Enhanced delivery epinephrine and prodrug compositions
|
|
US11273131B2
(en)
|
2016-05-05 |
2022-03-15 |
Aquestive Therapeutics, Inc. |
Pharmaceutical compositions with enhanced permeation
|
|
KR20230137362A
(ko)
|
2016-05-05 |
2023-10-04 |
어퀘스티브 테라퓨틱스, 아이엔씨. |
강화된 전달 에프네프린 조성물
|
|
US12427121B2
(en)
|
2016-05-05 |
2025-09-30 |
Aquestive Therapeutics, Inc. |
Enhanced delivery epinephrine compositions
|
|
US20180104250A1
(en)
|
2016-10-14 |
2018-04-19 |
Knowles Enterprises Inc. |
Formulations for treatment of migraines
|
|
WO2018102743A1
(en)
|
2016-12-02 |
2018-06-07 |
Bioverativ Therapeutics Inc. |
Methods of treating hemophilic arthropathy using chimeric clotting factors
|
|
WO2018200885A1
(en)
|
2017-04-26 |
2018-11-01 |
Neurocentria, Inc. |
Magnesium compositions and methods of use
|
|
RS66972B1
(sr)
|
2018-05-18 |
2025-07-31 |
Bioverativ Therapeutics Inc |
Metode lečenja hemofilije a
|
|
CN109453414A
(zh)
*
|
2018-09-26 |
2019-03-12 |
南阳市中心医院 |
一种肝胆外科术后抗感染的敷料
|
|
CA3182372A1
(en)
|
2020-06-25 |
2021-12-30 |
Amunix Pharmaceuticals, Inc. |
Her-2 targeted bispecific compositions and methods for making and using the same
|
|
WO2023076281A1
(en)
|
2021-10-25 |
2023-05-04 |
Aquestive Therapeutics, Inc. |
Oral and nasal compositions and methods of treatment
|